NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Last Close
May 23 04:00PM ET
1.89
Dollar change
+0.13
Percentage change
7.39
%
Index- P/E- EPS (ttm)-0.39 Insider Own2.08% Shs Outstand99.78M Perf Week15.95%
Market Cap188.58M Forward P/E- EPS next Y-0.38 Insider Trans0.97% Shs Float97.71M Perf Month41.04%
Income-27.13M PEG- EPS next Q-0.08 Inst Own14.33% Short Float7.89% Perf Quarter62.93%
Sales0.00M P/S- EPS this Y33.00% Inst Trans23.69% Short Ratio4.70 Perf Half Y46.51%
Book/sh0.31 P/B6.19 EPS next Y-11.94% ROA-91.36% Short Interest7.71M Perf Year33.10%
Cash/sh0.29 P/C6.62 EPS next 5Y50.68% ROE-144.90% 52W Range0.77 - 2.07 Perf YTD81.73%
Dividend Est.- P/FCF- EPS past 5Y45.94% ROI-96.65% 52W High-8.70% Beta2.29
Dividend TTM- Quick Ratio4.64 Sales past 5Y22.63% Gross Margin- 52W Low144.82% ATR (14)0.16
Dividend Ex-DateMar 24, 2011 Current Ratio4.64 EPS Y/Y TTM64.62% Oper. Margin- RSI (14)64.90 Volatility10.47% 6.12%
Employees15 Debt/Eq0.03 Sales Y/Y TTM- Profit Margin- Recom1.00 Target Price5.75
Option/ShortYes / Yes LT Debt/Eq0.01 EPS Q/Q68.99% Payout- Rel Volume1.88 Prev Close1.76
Sales Surprise- EPS Surprise33.33% Sales Q/Q- EarningsMay 13 AMC Avg Volume1.64M Price1.89
SMA2015.03% SMA5038.52% SMA20053.36% Trades Volume3,081,460 Change7.39%
Date Action Analyst Rating Change Price Target Change
Jul-21-21Initiated Cantor Fitzgerald Overweight $18
Nov-01-18Initiated Oppenheimer Outperform
Apr-02-18Initiated H.C. Wainwright Buy $11
Mar-19-18Upgrade Maxim Group Hold → Buy $13
May-21-25 06:00AM
May-20-25 08:00AM
May-15-25 08:45AM
May-13-25 04:05PM
Apr-28-25 08:45AM
10:23AM Loading…
Apr-23-25 10:23AM
Apr-08-25 08:45AM
Apr-05-25 12:37PM
Mar-31-25 03:03PM
Mar-20-25 04:05PM
Feb-27-25 10:10AM
Feb-21-25 07:29AM
Feb-20-25 08:45AM
Jan-28-25 03:11PM
Jan-23-25 08:10AM
08:20AM Loading…
Jan-08-25 08:20AM
Jan-02-25 08:00AM
Dec-10-24 08:30AM
Dec-09-24 08:45AM
Nov-28-24 05:37AM
Nov-27-24 08:45AM
Nov-13-24 04:15PM
Nov-05-24 09:55AM
Oct-15-24 08:45AM
Oct-10-24 04:05PM
Sep-18-24 03:09PM
Aug-13-24 04:10PM
Aug-06-24 08:45AM
Jul-31-24 08:30AM
Jul-16-24 09:05AM
08:45AM Loading…
Jul-08-24 08:45AM
Jun-24-24 09:05AM
Jun-17-24 09:45AM
09:05AM
Jun-10-24 08:40AM
May-14-24 10:54PM
04:05PM
May-01-24 08:35AM
Apr-29-24 08:45AM
Mar-28-24 10:54PM
04:05PM
07:00AM
Mar-26-24 07:35AM
Mar-19-24 04:05PM
08:47AM
Mar-15-24 09:00AM
Mar-08-24 08:00AM
Mar-01-24 08:30AM
Feb-29-24 08:00AM
Feb-06-24 08:30AM
Jan-25-24 08:45AM
Jan-11-24 06:00AM
Jan-10-24 11:30AM
Jan-09-24 08:30AM
Jan-04-24 09:01AM
08:41AM
Jan-03-24 08:05PM
07:30AM
Dec-27-23 08:55AM
Dec-21-23 08:15AM
Dec-14-23 08:30AM
Dec-13-23 08:30AM
Dec-04-23 08:47AM
Nov-29-23 08:45AM
Nov-13-23 08:50AM
Nov-09-23 04:04PM
Nov-06-23 08:57AM
Oct-31-23 08:05AM
Oct-30-23 09:03AM
Oct-17-23 08:45AM
Oct-16-23 08:45AM
Oct-12-23 04:05PM
Oct-11-23 08:30AM
Oct-10-23 04:15PM
07:00AM
Sep-21-23 08:30AM
Sep-18-23 04:19PM
Aug-22-23 08:30AM
Aug-10-23 04:08PM
Jul-15-23 09:25AM
Jun-28-23 04:00PM
08:30AM
Jun-22-23 08:45AM
Jun-15-23 04:05PM
Jun-13-23 08:30AM
May-25-23 05:05PM
May-16-23 08:30AM
May-11-23 04:12PM
May-04-23 08:30AM
Apr-26-23 04:01PM
Apr-20-23 08:30AM
Apr-18-23 08:30AM
Mar-16-23 04:11PM
Mar-07-23 08:30AM
Feb-24-23 08:42AM
08:30AM
07:29AM
Feb-23-23 04:01PM
Feb-05-23 07:57AM
Jan-19-23 08:30AM
SELLAS Life Sciences Group, Inc. is a clinical stage biopharmaceutical company, which engages in the development and commercialization of immunotherapeutic for cancer indications. Its product pipeline includes galinpepimut-S. The company was founded by Angelos M. Stergiou on April 3, 2006 and is headquartered in New York, NY.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Kalin Katherine BachDirectorMay 22 '25Buy1.8020,00036,00041,000May 22 04:05 PM